Inversago Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Inversago Pharma's estimated annual revenue is currently $2.4M per year.
- Inversago Pharma's estimated revenue per employee is $100,500
Employee Data
- Inversago Pharma has 24 Employees.
- Inversago Pharma grew their employee count by -11% last year.
Inversago Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | Head Chemistry | Reveal Email/Phone |
4 | VP, Finance and Administration | Reveal Email/Phone |
5 | VP, Clinical Operations | Reveal Email/Phone |
6 | VP Pharmacology and PK | Reveal Email/Phone |
7 | Head Chemistry | Reveal Email/Phone |
8 | Associate Director | Reveal Email/Phone |
9 | Senior Director Preclinical Development | Reveal Email/Phone |
10 | Senior Director Quality Assurance | Reveal Email/Phone |
Inversago Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 13 | -28% | N/A | N/A |
#2 | $21.3M | 106 | -29% | N/A | N/A |
#3 | $3.6M | 18 | 50% | N/A | N/A |
#4 | $10.7M | 105 | 5% | $39.7M | N/A |
#5 | $55.5M | 276 | 45% | N/A | N/A |
#6 | $57.9M | 288 | N/A | N/A | N/A |
#7 | $18.7M | 93 | 6% | N/A | N/A |
#8 | $478.8M | 2382 | 7% | N/A | N/A |
#9 | $202.2M | 1006 | 8% | N/A | N/A |
#10 | $437.6M | 2177 | 6% | N/A | N/A |
What Is Inversago Pharma?
Located in Montreal, Inversago Pharma is a privately-owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic nephropathy, Non-Alcoholic Steatohepatitis (NASH), complications of obesity, hypertriglyceridemia (HTG) and Type 1 Diabetes (T1D), Prader-Willi Syndrome (PWS), as well as fibrotic indications such as Progressive Fibrosis – Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF).
keywords:N/A
N/A
Total Funding
24
Number of Employees
$2.4M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Montreal
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 24 | 33% | N/A |
#2 | $2.4M | 24 | -14% | N/A |
#3 | $2.4M | 24 | N/A | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $3.7M | 24 | N/A | N/A |